Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Sep 19, 2016
Insider Transaction Report
Form 4
Harris Robert Paul
Director
Transactions
- Sale
Common Shares, without par value
2016-09-15$5.60/sh−75,000$420,000→ 669,094 total
Holdings
- 600,188(indirect: By Spouse)
Common Shares, without par value
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2016.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.00 to $6.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.